Bristol Myers Squibb (BMS) has announced that the European
Commission has granted an approval for Baraclude (entecavir) for
the treatment of chronic hepatitis B virus (HBV) infection.
DanioLabs has announced the start of a Phase I proof-of-concept
trial of DL06001 and DL06002 for sialorrhoea (drooling) and
hyperhidrosis (excessive sweating) in Parkinson's disease as the
company aim to meet the need for treating...
Tripos has introduced its answer to rapid in-silico drug screening
with its virtual screening software that uses a fully automatic
flexible molecular docking algorithm to offer speed, accuracy and
usability advantages over current...
Chi-Med has been given the Food and Drug Administraton (FDA) green
light to broaden its oncology drug candidate clinical trials after
it exhibited encouraging results, which the company want to expand
into a much wider patient population...
ExonHit Therapeutics was present at the PiperJaffray healthcare
conference in London giving investors updates on company activity
over the last year. The company are coming off the back of a patent
application, which covers a number...
Applied Biosystems (AB) is to acquire Agencourt Personal Genomics
(APG) for approximately $120m (€94m) in cash in which the life
science specialists will gain a novel, high throughput approach
with applications in DNA sequencing,...
European life sciences received an unexpected boost as the European
Science Foundation launched an initiative to help promote and
coordinate interaction among European life sciences researchers and
funders.
ChemGenex has teamed up with MolecularMD in a deal that focuses on
a drug resistance mutation seen in chronic myeloid leukemia (CML)
patients, which has seen these sufferers no longer respond to
Gleevec, a popular cancer treatment.
Vertex Pharmaceutcals was one of a number of pharma and biotech
companies to attend the PiperJaffray healthcare conference in
London last week, which gave international companies the
opportunity to provide pipeline updates.
BioPharmaceutical company Protherics, were on hand at the
PiperJaffray conference providing pipeline and company updates to a
audience of investors and analysts. The company are coming off the
back of a successful deal with Astrazeneca...
Software provider, PDS Pathology Data Systems have announced it can
now provide Internet access to its specialised post-mortem
functionality system to users that include University research
departments, CROs, Biotechs and smaller...
Roche took the opportunity to reassure investors and analysts as it
outlined its plans to deal with the impending threat to Avastin and
Herceptin. Roche's new indications for cancer treatments suggest
that its oncology portfolio...
Nalgene introduces its sterile disposable shaker flask that
incorporates a larger volume capacity for single-use. Its design
aims to reduce the risk of cross contamination.
Asterand has announced the formation of a partnership with Rubicon
Genomics to develop new cancer diagnostic tests that identify the
DNA methylation mechanism that causes cells to become cancerous
making the assignment of treatment...
Peakdale Molecular has taken the opportunity to expand its
capabilities and capacity extending the services it can provide to
further support customers' drug discovery challenges.
Applied Biosystems (AB) has given drug researchers a new software
application in thier quest to more quickly and accurately screen
drug candidates, which can be further developed into promising new
treatments.
EntreMed has produced hard data demonstrating antiangiogenic
activity of its lead compound against the devastating effects of
rheumatoid arthritis (RA). The results pave the way to developing
therapeutics for the cancer and inflammatory...
A toxic group of plant extracts has been found to protect animal
tissue against the lack of blood that occurs in stroke giving rise
to a new direction in the development of stroke treatment.
A new report has blasted pharmaceutical companies for its use of
unscrupulous marketing practices, accusing the drug producers of
misleading physicians of a drug's effectiveness and convincing
consumers of the drug's importance.
Quest Pharmaceutical Services (QPS) has announced the launch of its
new Molecular Biology Services that aims to integrate
pharmacogenomics into drug development programs to deliver more
effective compounds to the market quicker.
Chinese scientists think they might have discovered what activates
the development of Leukaemia signalling a novel direction in which
new therapies can result to treat a disease that afflicts millions
worldwide.
Odyessa Thera has announced it has been granted a US patent for its
single-and multi-colour protein-fragment complementation assays
(PCA), which can be applied to high throughput drug discovery.
A recently published report has highlighted the use of antibiotics
in the rearing of fish could promote bacterial resistance leading
to the evolution of resistant strains of bacteria in humans as well
as the fish themselves.
Pliva's venture into the Indian subcontinent received a boost as it
was revealed the Governor of Goa would inaugurate the newly built
research and development facility of Pliva Research, India.
GlaxosmithKline (GSK) has agreed to continue its collaboration with
CytoKinetics, which focused towards the mitotic kinesin,
centromere-associated protein E (CENP-E) that has evolved to become
a novel and viable drug target.
Preclinical data from Vical's avian flu DNA vaccine program has
resulted in the company coming one step closer to $2.6m (€2m) in
funding for further development of the vaccine under a grant
awarded by the US government.
Following a recent report that predicted the use of apes in animal
testing would be unavoidable in the future, Spain could become the
first country worldwide to give some primate species fundamental
rights that are granted to human...
Drug companies have been encouraged by recent studies that suggest
that by blocking the binding of transcription factors may be a way
to short-circuit the harmful effects of diseases.
Researchers believe that the effectiveness of from a commonly used
asthma medicine may be compromised by a gene variation, which is
present in around 13 per cent of the city's population.
CureTech has revealed it has wrapped up a deal in which Teva
Pharmaceuticals will invest $6m (€4.7m) in CureTech, for the
development of a revolutionary cancer drug, based on the company's
potential value of $64m.
According to a new report, key trends that are occurring within
pharma-biotech alliances, as well as within biotech-biotech
alliances, are having to grapple with safety concerns and efficacy,
which have made biotech a high-risk area...
Nanogen introduces its latest enterovirus reagent, which employs
hybridisation technology designed to detect
enteroviruses-associated sequences. Enterovirus infections cause a
wide spectrum of diseases and are the most common cause...
Galapagos are to acquire the drug discovery service operations of
Discovery Partners International for $6.4m in a move that cements
Galapagos' BioFocus division as a top three provider in drug
discovery services worldwide.
The Cambrex Corporation and Cytori Therapeutics have formed a
collaboration that aims to provide adipose-derived stem cell
products globally for use in basic and translational bioresearch.
Tripos has announced the release of the latest version of its
visualisation platform that allows laboratory scientists to make
better informed decisions based on the three-dimensional molecular
information it produces.
Liquid handling specialists Anachem has made available a recycling
programme for the waste polypropylene racks produced by its new
range of high quality robotic tips designed to fit Tecan, Qiagen,
Beckman or Gilson Robotic Platforms.
Invitrogen has formed a collaboration to supply reagents for
Solexa's Genome Analysis System, a sequencing technology that has
the potential to generate over a billion bases of DNA sequence data
per run.
Invitrogen has announced the opening of a new research facility to
be located in Scotland. The decision adds to the investment influx
within the region, which has seen 20 per cent of the UK's biotech
companies set up research...
PerkinElmer has launched a new antibody-free kinase assay
technology that is set to play a major role in drug discovery by
allowing researchers to perform direct measurements of kinase
activities on full-length protein substrates...
Velocity11 has made available globally, a gripper accessory for its
Bravo Liquid Handling Platform that enables a broader range of
fully automated applications to be achieved by the compact Bravo
platform.
A study that has uncovered core functional differences between a
new oestrogen receptor could form the basis of novel and
potentially more effective treatments of breast cancer as
researchers sought to utilise this therapeutic target.
A membrane protein factory, which represents over half of all known
drug targets could lead to new and improved pharmaceutical
treatments for a broad range of illnesses such as depression, heart
disease, addictions and cystic fibrosis.
Applied Biosystems (AB) make available a wider range of microRNA
assays, expanding the selection to 300 individual assays that are
ideal for cell differentiation, developmental biology, stem cell
and cancer research.
Scientists believe they have made a breakthrough in the fight
against HIV drug resistance by developing a drug that is the first
in a new class of HIV drug candidates called Maturation Inhibitors.
Medical innovations company BTG, continued its progress on the
strategy it implemented last May by revealing its operating
highlights that has seen six new programmes added to its product
pipeline.
AstraZeneca sought to reassure investors this week by providing an
update on progress made in strengthening its product pipeline, a
worry for industry analysts who believe its existing products
cannot underpin earnings growth for...
Contract research company, EpiStem have announced the successful
installation of an automated imaging system that now enables the
firm to expand the range and throughput of its services in
immunohistochemistry (IHC) and histometric...
Pharmaceutical companies looking to eliminate manual handling of
samples to enhance productivity may want to look at Genevac's new
automated centrifugal evaporators.
A new class of drug that targets breast cancer by blocking
production of oestrogen and reducing serious side effects for many
more, could eventually become the gold-standard for cancer
treatment.